The use of hydroxyethyl starch for acute volume resuscitation in critically ill patients is associated with serious safety concerns, according to the authors of a recent paper published in the Journal ...

Intravenous use of hydroxyethyl starch to increase blood volume and revive critically ill patients is not only not associated with decreased mortality but, when questionable research is excluded from ...

High-molecular-weight hydroxyethyl starches (hetastarches) can cause acquired type I von Willebrand's disease. 1 A case has also occurred after treatment with medium-molecular-weight hydroxyethyl ...

There are currently 4 FDA-approved hydroxyethyl starch products on the market. The Food and Drug Administration (FDA) is requiring that the Boxed Warning for hydroxyethyl starch products be amended to ...

Clinicians should not use hydroxyethyl starch (HES) solution in critically ill patients, including those with sepsis and those admitted to the intensive care unit, the US Food and Drug Administration ...

The increased risk of kidney injury related to the use of hydroxyethyl starch in resuscitation fluids reflects the mass of HES molecules, according to a report. Hydroxyethyl starch is a starch ...

A new study published in the journal Anesthesia & Analgesia suggests using hydroxyethyl starch (HES) in resuscitation fluids leads to higher levels of HES molecules mass, thereby increasing the risk ...

In 2012, the results of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST) were published. 1 CHEST was an investigator-initiated, randomized, controlled trial in which 6% hydroxyethyl starch ...